NCT07152938View on ClinicalTrials.gov

Augmented Virtual Reality for Reducing Pain, Stress, Anxiety and Improve Self Efficacy in Adult Cancer Patients Undergoing Chemotherapy in The West Bank

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

October 30, 2023

Conditions
Cancer and Chemotherapy Related AnemiaCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)
Interventions
BEHAVIORAL

AVR Group (Chemotherapy + AVR)

the intervention group received AVR before they started treatment and during the session. The researcher administered the posttest questionnaire The questionnaire assessed immediately after finishing AVR. Participants informed not to discuss AVR with each other's, as the researcher explained to the participants the purpose of the study and their participation will not affect their care or treatment

Trial Locations (3)

00970

Jenin governmental hospital, Jenin

AL-Watni governmental hospital, Nablus

Thabet Thabet governmental hospital, Tulkarm

All Listed Sponsors
lead

Arab American University (Palestine)

OTHER

NCT07152938 - Augmented Virtual Reality for Reducing Pain, Stress, Anxiety and Improve Self Efficacy in Adult Cancer Patients Undergoing Chemotherapy in The West Bank | Biotech Hunter | Biotech Hunter